The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.

BACKGROUND: The dynamic intersection of a pluralistic health system, large informal sector, and poor regulatory environment have provided conditions favourable for 'corruption' in the LMICs of south and south-east Asia region. 'Corruption' works to undermine the UHC goals of achieving equity, quality, and responsiveness including financial protection, especially while delivering frontline health care services. This scoping review examines current situation regarding health sector corruption at frontlines of service delivery in this region, related policy perspectives, and alternative strategies currently being tested to address this pervasive phenomenon. METHODS: A scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) was conducted, using three search engines i.e., PubMed, SCOPUS and Google Scholar. A total of 15 articles and documents on corruption and 18 on governance were selected for analysis. A PRISMA extension for Scoping Reviews (PRISMA-ScR) checklist was filled-in to complete this report. Data were extracted using a pre-designed template and analysed by 'mixed studies review' method. RESULTS: Common types of corruption like informal payments, bribery and absenteeism identified in the review have largely financial factors as the underlying cause. Poor salary and benefits, poor incentives and motivation, and poor governance have a damaging impact on health outcomes and the quality of health care services. These result in high out-of-pocket expenditure, erosion of trust in the system, and reduced service utilization. Implementing regulations remain constrained not only due to lack of institutional capacity but also political commitment. Lack of good governance encourage frontline health care providers to bend the rules of law and make centrally designed anti-corruption measures largely in-effective. Alternatively, a few bottom-up community-engaged interventions have been tested showing promising results. The challenge is to scale up the successful ones for measurable impact. CONCLUSIONS: Corruption and lack of good governance in these countries undermine the delivery of quality essential health care services in an equitable manner, make it costly for the poor and disadvantaged, and results in poor health outcomes. Traditional measures to combat corruption have largely been ineffective, necessitating the need for innovative thinking if UHC is to be achieved by 2030.

Doctors of interest. Recipients of suspect drug-company payments academic medical centers, have drawing attention of federal fraud enforcers.

As the federal government begins to focus more on wasteful healthcare spending, doctors' relationships with drug companies are coming under scrutiny. Many times, those relationships are legitimate, says Mary Riordan, left, a senior counsel to HHS' inspector general's office. "There are other situations where the relationship between the doctor and the manufacturer is suspect".

Fraud and abuse enforcement trends. What's hot for physicians and physician practices.

The Department of Health and Human Services Office of Inspector General (OIG) has dramatically expanded the scope and frequency of physician fraud and abuse investigations. Further, OIG has increasingly extracted financial settlements and obtained sanctions against physicians. This article identifies seven areas of investigation that will be given highest priority.

How provider fraud flattens corporate profits.

New laws are giving the private sector some real enforcement clout--and a better shot at recovering or preserving huge sums of money at a time when other dampers on costs are screwed down about as tight as they can get.